LivaNova Future Growth
Future criteria checks 3/6
LivaNova is forecast to grow earnings and revenue by 41.2% and 4.6% per annum respectively. EPS is expected to grow by 43.6% per annum. Return on equity is forecast to be 12.7% in 3 years.
Key information
41.2%
Earnings growth rate
43.6%
EPS growth rate
Medical Equipment earnings growth | 17.7% |
Revenue growth rate | 4.6% |
Future return on equity | 12.7% |
Analyst coverage | Good |
Last updated | 10 Jun 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,350 | 117 | 299 | N/A | 9 |
12/31/2025 | 1,279 | 92 | 476 | N/A | 9 |
12/31/2024 | 1,216 | 39 | 729 | N/A | 9 |
3/31/2024 | 1,185 | -32 | 30 | 64 | N/A |
12/31/2023 | 1,154 | 18 | 40 | 75 | N/A |
9/30/2023 | 1,118 | 3 | 8 | 40 | N/A |
6/30/2023 | 1,085 | -97 | 29 | 57 | N/A |
3/31/2023 | 1,045 | -82 | 36 | 65 | N/A |
12/31/2022 | 1,022 | -86 | 43 | 70 | N/A |
9/30/2022 | 1,017 | -93 | 60 | 85 | N/A |
6/30/2022 | 1,018 | -29 | 51 | 73 | N/A |
3/31/2022 | 1,028 | -102 | 86 | 109 | N/A |
12/31/2021 | 1,035 | -136 | 77 | 103 | N/A |
9/30/2021 | 1,035 | -414 | 82 | 106 | N/A |
6/30/2021 | 1,022 | -385 | 59 | 91 | N/A |
3/31/2021 | 939 | -417 | 11 | 46 | N/A |
12/31/2020 | 934 | -347 | -114 | -79 | N/A |
9/30/2020 | 952 | -208 | -150 | -114 | N/A |
6/30/2020 | 981 | -161 | -234 | -199 | N/A |
3/31/2020 | 1,076 | -102 | -230 | -199 | N/A |
12/31/2019 | 1,084 | -158 | -116 | -91 | N/A |
9/30/2019 | 1,094 | -222 | -106 | -73 | N/A |
6/30/2019 | 1,097 | -260 | 19 | 55 | N/A |
3/31/2019 | 1,107 | -211 | 63 | 102 | N/A |
12/31/2018 | 1,107 | -178 | 82 | 120 | N/A |
9/30/2018 | 1,088 | 0 | 82 | 117 | N/A |
6/30/2018 | 1,068 | 33 | 76 | 108 | N/A |
3/31/2018 | 1,036 | 59 | 47 | 79 | N/A |
12/31/2017 | 1,012 | 54 | N/A | 91 | N/A |
9/30/2017 | 795 | 121 | N/A | 114 | N/A |
6/30/2017 | 840 | 92 | N/A | 109 | N/A |
3/31/2017 | 905 | 55 | N/A | 114 | N/A |
12/31/2016 | 965 | 2 | N/A | 90 | N/A |
12/31/2015 | 545 | -22 | N/A | -14 | N/A |
10/18/2015 | 295 | 14 | N/A | 87 | N/A |
7/24/2015 | 301 | 57 | N/A | 80 | N/A |
4/24/2015 | 292 | 58 | N/A | 80 | N/A |
1/23/2015 | 292 | 66 | N/A | 80 | N/A |
10/24/2014 | 288 | 63 | N/A | 75 | N/A |
7/25/2014 | 285 | 60 | N/A | 63 | N/A |
4/25/2014 | 282 | 55 | N/A | 54 | N/A |
1/24/2014 | 276 | 48 | N/A | 61 | N/A |
10/25/2013 | 270 | 47 | N/A | 67 | N/A |
7/26/2013 | 263 | 47 | N/A | 74 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: L2IV34 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (9.9%).
Earnings vs Market: L2IV34 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: L2IV34 is expected to become profitable in the next 3 years.
Revenue vs Market: L2IV34's revenue (4.6% per year) is forecast to grow slower than the BR market (7.1% per year).
High Growth Revenue: L2IV34's revenue (4.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: L2IV34's Return on Equity is forecast to be low in 3 years time (12.7%).